These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26933857)

  • 1. Nicotinamide for Skin-Cancer Chemoprevention.
    Zhao Y
    N Engl J Med; 2016 Feb; 374(8):789. PubMed ID: 26933857
    [No Abstract]   [Full Text] [Related]  

  • 2. Nicotinamide for Skin-Cancer Chemoprevention.
    Chen AC; Martin AJ; Damian DL
    N Engl J Med; 2016 Feb; 374(8):790. PubMed ID: 26933856
    [No Abstract]   [Full Text] [Related]  

  • 3. Nicotinamide for Skin-Cancer Chemoprevention.
    Drago F; Ciccarese G; Parodi A
    N Engl J Med; 2016 Feb; 374(8):789-90. PubMed ID: 26933858
    [No Abstract]   [Full Text] [Related]  

  • 4. Skin cancer: Nicotinamide reduces new skin cancer risk.
    Sidaway P
    Nat Rev Clin Oncol; 2016 Jan; 13(1):4. PubMed ID: 26525684
    [No Abstract]   [Full Text] [Related]  

  • 5. Nicotinamide found to reduce the rate of nonmelanoma skin cancers in high-risk patients.
    Barton MK
    CA Cancer J Clin; 2016; 66(2):91-2. PubMed ID: 26754863
    [No Abstract]   [Full Text] [Related]  

  • 6. ACP Journal Club. In high-risk patients, oral nicotinamide reduced number of new nonmelanoma skin cancers during treatment.
    Hajdenberg J
    Ann Intern Med; 2016 Feb; 164(4):JC18. PubMed ID: 26882303
    [No Abstract]   [Full Text] [Related]  

  • 7. Nicotinamide for skin cancer chemoprevention.
    Damian DL
    Australas J Dermatol; 2017 Aug; 58(3):174-180. PubMed ID: 28321860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.
    Chen AC; Martin AJ; Choy B; Fernández-Peñas P; Dalziell RA; McKenzie CA; Scolyer RA; Dhillon HM; Vardy JL; Kricker A; St George G; Chinniah N; Halliday GM; Damian DL
    N Engl J Med; 2015 Oct; 373(17):1618-26. PubMed ID: 26488693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide for prevention of nonmelanoma skin cancers: a change in practice?
    Nestor L; Clowry J; Molloy K; Connolly M; Salim A; Tobin AM
    Clin Exp Dermatol; 2017 Dec; 42(8):945-946. PubMed ID: 29044731
    [No Abstract]   [Full Text] [Related]  

  • 10. Nicotinamide: New Indications in Dermatology.
    Escudero-Góngora MM; Fernández-Peñas P
    Actas Dermosifiliogr; 2016 Nov; 107(9):777-778. PubMed ID: 27377936
    [No Abstract]   [Full Text] [Related]  

  • 11. Current Practices for Preventative Interventions for Nonmelanoma Skin Cancers Among Dermatologic Surgeons.
    Arzeno J; Leavitt E; Lonowski S; Kim J
    Dermatol Surg; 2021 Jul; 47(7):995-997. PubMed ID: 33587370
    [No Abstract]   [Full Text] [Related]  

  • 12. Nicotinamide and skin cancer chemoprevention: The jury is still out.
    Gilmore SJ
    Australas J Dermatol; 2018 Feb; 59(1):6-9. PubMed ID: 29192960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma and nonmelanoma skin cancer chemoprevention: A role for nicotinamide?
    Minocha R; Damian DL; Halliday GM
    Photodermatol Photoimmunol Photomed; 2018 Jan; 34(1):5-12. PubMed ID: 28681504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials.
    Surjana D; Halliday GM; Martin AJ; Moloney FJ; Damian DL
    J Invest Dermatol; 2012 May; 132(5):1497-500. PubMed ID: 22297641
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclo-oxygenase-2 inhibitors for chemoprevention of nonmelanoma skin cancer: is there a role for these agents?
    Liebman TN; Stein JA; Polsky D
    J Am Acad Dermatol; 2013 Jan; 68(1):173-6. PubMed ID: 23244374
    [No Abstract]   [Full Text] [Related]  

  • 16. Periocular actinic keratosis, keratinocyte carcinomas, and eyeglasses use.
    Lee KC; Weinstock MA;
    J Am Acad Dermatol; 2013 Jul; 69(1):165-7. PubMed ID: 23768294
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: Systematic review and meta-analyses.
    Tee LY; Sultana R; Tam SYC; Oh CC
    J Am Acad Dermatol; 2021 Feb; 84(2):528-530. PubMed ID: 32387631
    [No Abstract]   [Full Text] [Related]  

  • 18. Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.
    Allen NC; Martin AJ; Snaidr VA; Eggins R; Chong AH; Fernandéz-Peñas P; Gin D; Sidhu S; Paddon VL; Banney LA; Lim A; Upjohn E; Schaider H; Ganhewa AD; Nguyen J; McKenzie CA; Prakash S; McLean C; Lochhead A; Ibbetson J; Dettrick A; Landgren A; Allnutt KJ; Allison C; Davenport RB; Mumford BP; Wong B; Stagg B; Tedman A; Gribbin H; Edwards HA; De Rosa N; Stewart T; Doolan BJ; Kok Y; Simpson K; Low ZM; Kovitwanichkanont T; Scolyer RA; Dhillon HM; Vardy JL; Chadban SJ; Bowen DG; Chen AC; Damian DL
    N Engl J Med; 2023 Mar; 388(9):804-812. PubMed ID: 36856616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study.
    Drago F; Ciccarese G; Cogorno L; Calvi C; Marsano LA; Parodi A
    Eur J Dermatol; 2017 Aug; 27(4):382-385. PubMed ID: 28468736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer.
    Nemer KM; Council ML
    Dermatol Clin; 2019 Jul; 37(3):287-295. PubMed ID: 31084723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.